137 related articles for article (PubMed ID: 27210083)
1. [Missile-Type Tumor-Targeting Polymer Drug, P-THP, Seeks Tumors via Three Different Steps Based on the EPR Effect].
Maeda H; Fang J; Ulbrich K; Etrych T; Nakamura H
Gan To Kagaku Ryoho; 2016 May; 43(5):549-57. PubMed ID: 27210083
[TBL] [Abstract][Full Text] [Related]
2. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
[TBL] [Abstract][Full Text] [Related]
3. Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage.
Nakamura H; Etrych T; Chytil P; Ohkubo M; Fang J; Ulbrich K; Maeda H
J Control Release; 2014 Jan; 174():81-7. PubMed ID: 24269967
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and therapeutic effect of styrene-maleic acid copolymer-conjugated pirarubicin.
Tsukigawa K; Liao L; Nakamura H; Fang J; Greish K; Otagiri M; Maeda H
Cancer Sci; 2015 Mar; 106(3):270-8. PubMed ID: 25529761
[TBL] [Abstract][Full Text] [Related]
5. Comparison between linear and star-like HPMA conjugated pirarubicin (THP) in pharmacokinetics and antitumor activity in tumor bearing mice.
Nakamura H; Koziolová E; Etrych T; Chytil P; Fang J; Ulbrich K; Maeda H
Eur J Pharm Biopharm; 2015 Feb; 90():90-6. PubMed ID: 25460144
[TBL] [Abstract][Full Text] [Related]
6. [Development of Tumor-targeting Antitumor Agents Based on Polymer Effect].
Nakamura H
Yakugaku Zasshi; 2020; 140(10):1243-1249. PubMed ID: 32999203
[TBL] [Abstract][Full Text] [Related]
7. HPMA copolymer conjugate with pirarubicin: In vitro and ex vivo stability and drug release study.
Islam W; Fang J; Etrych T; Chytil P; Ulbrich K; Sakoguchi A; Kusakabe K; Maeda H
Int J Pharm; 2018 Jan; 536(1):108-115. PubMed ID: 29133205
[TBL] [Abstract][Full Text] [Related]
8. HPMA Copolymer-Conjugated Pirarubicin in Multimodal Treatment of a Patient with Stage IV Prostate Cancer and Extensive Lung and Bone Metastases.
Dozono H; Yanazume S; Nakamura H; Etrych T; Chytil P; Ulbrich K; Fang J; Arimura T; Douchi T; Kobayashi H; Ikoma M; Maeda H
Target Oncol; 2016 Feb; 11(1):101-6. PubMed ID: 26194363
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of primary and metastatic tumors in mice by E-selectin-targeted polymer-drug conjugates.
Shamay Y; Raviv L; Golan M; Voronov E; Apte RN; David A
J Control Release; 2015 Nov; 217():102-12. PubMed ID: 26297207
[TBL] [Abstract][Full Text] [Related]
10. Superior Penetration and Cytotoxicity of HPMA Copolymer Conjugates of Pirarubicin in Tumor Cell Spheroid.
Nakamura H; Koziolová E; Chytil P; Etrych T; Haratake M; Maeda H
Mol Pharm; 2019 Aug; 16(8):3452-3459. PubMed ID: 31294568
[No Abstract] [Full Text] [Related]
11. Copoly(styrene-maleic acid)-pirarubicin micelles: high tumor-targeting efficiency with little toxicity.
Greish K; Nagamitsu A; Fang J; Maeda H
Bioconjug Chem; 2005; 16(1):230-6. PubMed ID: 15656596
[TBL] [Abstract][Full Text] [Related]
12. Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer.
Duncan R; Vicent MJ; Greco F; Nicholson RI
Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S189-99. PubMed ID: 16113096
[TBL] [Abstract][Full Text] [Related]
13. pH-Responsive Polymer Conjugate of Pirarubicin With Styrene Maleic Acid Copolymer as a Potential Therapeutic for Ovarian Cancer.
Liu L; Sun J; Yin H; Fang J; Jin X
J Pharm Sci; 2016 May; 105(5):1595-1602. PubMed ID: 27020984
[TBL] [Abstract][Full Text] [Related]
14. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
Maeda H; Bharate GY; Daruwalla J
Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
[TBL] [Abstract][Full Text] [Related]
15. Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulations.
Lammers T
Adv Drug Deliv Rev; 2010 Feb; 62(2):203-30. PubMed ID: 19951732
[TBL] [Abstract][Full Text] [Related]
16. Acid-responsive HPMA copolymer-bradykinin conjugate enhances tumor-targeted delivery of nanomedicine.
Appiah E; Nakamura H; Pola R; Grossmanová E; Lidický O; Kuniyasu A; Etrych T; Haratake M
J Control Release; 2021 Sep; 337():546-556. PubMed ID: 34375687
[TBL] [Abstract][Full Text] [Related]
17. Development of a Selective Tumor-Targeted Drug Delivery System: Hydroxypropyl-Acrylamide Polymer-Conjugated Pirarubicin (P-THP) for Pediatric Solid Tumors.
Makimoto A; Fang J; Maeda H
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359599
[TBL] [Abstract][Full Text] [Related]
18. Effect of Tumor Targeted-Anthracycline Nanomedicine, HPMA Copolymer-Conjugated Pirarubicin (P-THP) against Gynecological Malignancies.
Yanazume S; Fang J; Islam R; Gao S; Kobayashi H
J Pers Med; 2022 May; 12(5):. PubMed ID: 35629236
[TBL] [Abstract][Full Text] [Related]
19. HPMA copolymer conjugated 5-aminolevulinic acid exhibits superior efficacy for photodynamic therapy with tumor-responsive and targeting properties.
Islam R; Kotalík K; Šubr V; Gao S; Zhou JR; Yokomizo K; Etrych T; Fang J
Nanomedicine; 2023 Feb; 48():102636. PubMed ID: 36549553
[TBL] [Abstract][Full Text] [Related]
20. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
